| VRTX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VRTX market cap history going back to 2/16/2010:
Also see: VRTX Shares Outstanding History and VRTX YTD Return |
VRTX Market Cap History — Vertex Pharmaceuticals Capitalization Over Time
As of 4/30/2026 Vertex Pharmaceuticals has a market cap of 108.47 billion. Investors often follow the VRTX market cap history to compare the size of the company over time.
This page shows VRTX market capitalization trends over time, with 64 market cap datapoints presented, dating back to 2/16/2010.
| VRTX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VRTX Historical Market Cap: +17.67% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VRTX Stock Price Chart |
| About Vertex Pharmaceuticals, Inc. |
| Vertex Pharmaceuticals Incorporated is a global biotechnology company. Co. is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. We show 64 historical shares outstanding datapoints in our VRTX shares outstanding history coverage, used to compute VRTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VRTX market cap history over the course of time is important for investors interested in comparing VRTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VRTX versus a peer is one thing; comparing VRTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VRTX can fluctuate over the course of history. With this page we aim to empower investors researching VRTX by allowing them to research the VRTX market cap history. |
| VRTX Current Stock Quote |
Quotes delayed 20 minutes  Free VRTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| VRTX Share Performance |
| Market Cap Peers |
| Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VRX Market Cap History VSAR Market Cap History VSTM Market Cap History VTGN Market Cap History VTL Market Cap History VTRS Market Cap History VTVT Market Cap History VTYX Market Cap History VVOS Market Cap History VVUS Market Cap History More Healthcare companies » |
VRTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
